- Substance
- Cartalax
- Purity (HPLC)
- 99.74%
- Potency
- 10.21 mg (102.1 %)
- Batch Number
- Cartalax10-J13
- Test Date
- 8/25/2026

Cartalax is a synthetic short-chain peptide bioregulator of the Khavinson series, derived from cartilage-tissue peptide fractions and studied in preclinical models for chondrocyte gene-expression signaling. Published sources differ on the exact residue count, so no full sequence is stated here. Supplied as a lyophilized powder for laboratory research, third-party tested with a certificate of analysis from an independent laboratory, for research use only — not for human or veterinary use.
Supplied lyophilized — requires BAC waterReview the available third-party certificate for each listed strength. Match its batch number to your vial, then open the full report for the reported purity, potency and identity results.
Research compounds our customers frequently order alongside this one.
Technical specifications
Research-grade peptides with published lab documentation, fast shipping, and dedicated research support.


Lyophilized (powder)
-20°C · up to 2 years
Reconstituted
2-8°C · up to 30 days